There are no cross-related applications.
The present application generally relates to hyperbaric and/or hypoxic chambers and chamber systems and, more particularly, to portable hyperbaric and/or hypoxic chambers and chamber systems.
Hyperbaric chambers and chamber systems are well known and used in the medical and sports industries. In essence, occupants of hyperbaric chambers undergo hyperbaric treatments in which they are subjected to relatively high pressures. Hyperbaric treatments are known, amongst other things, to enhance muscular recuperation and to increase oxygen inhalation.
In hypoxic chambers and chamber systems, the occupant is subjected to lower oxygen contents such as to simulate high altitudes. For their part, hypoxic treatments are known, amongst other things, to stimulate the production of red blood cells.
Conventional hyperbaric chambers are typically made of rigid materials capable of withstanding pressure differentials. Accordingly, hyperbaric treatments are not commonly accessible and are often only available to elite-level athletes and selected patients.
Accordingly, portable hyperbaric chambers have been developed to become more accessible. Examples of portable hyperbaric chambers are described in U.S. Pat. Nos. 3,877,427; 5,109,837; 5,255,673; 5,738,093; 6,321,746 and in International Patent Application Nos. PCT/GB2004/001139 (published under no. WO 2004/082552), and PCT/CA2007/001365 (published under no. WO 2008/014617).
However, prior art portable chambers have some shortcomings. For instance, some of the prior art chambers are not sturdy and therefore not durable. Other prior art chambers have complex construction, making them difficult to disassemble for transport. Still some other prior art chambers are limited to hyperbaric treatments.
Hence, despite ongoing developments in the field of hyperbaric and hypoxic chambers, there is still a need for an improved portable chamber which will mitigate the shortcomings of prior art portable chambers used for hyperbaric and/or hypoxic treatments.
An improved portable chamber for hyperbaric and/or hypoxic treatment in accordance with the principles of the present invention generally mitigates the shortcomings of prior art chambers by being easily disassembled and collapsed for transport and yet sturdy enough to sustain significant pressure (e.g. typically 30 psig and up to 180 psig).
Hence, a portable chamber in accordance with the principles of the present invention generally comprises an open-ended and typically frustro-conical tubular body suitably sized to accommodate at least one occupant, and two end members respectively configured to be received at opposite extremities of the body for closing the body in a seal tight arrangement.
The body is made of a flexible yet reinforced elastomeric material such as to be collapsible during transport yet resistant enough to sustain hyperbaric pressure (e.g. typically 30 psig and up to 180 psig) during hyperbaric treatment.
The body is typically made of a latex-neoprene elastomeric composition and is typically reinforced with aramid fibers or filaments. The aramid filaments are typically, though not necessarily, wound about the body at an angle of ±54.7° with respect to the central axis of the body.
The end members of the chamber are made of rigid reinforced material. The end members are typically made of a fiberglass/epoxy composition having a polymeric foam core.
One of the end members, typically the larger one, is provided with a displaceable door to provide access to the interior of the chamber. The door is secured to the larger end member via a locking ring assembly.
The door and the smaller end member are typically each provided with a window.
The extremities of the body are substantially spherical (i.e. inwardly rounded) such as to receive the correspondingly substantially spherical (or rounded) periphery of the end members. With this particular configuration, when the chamber is supplied with gases during hyperbaric or hypoxic treatment, the exterior surfaces of the spherical peripheries of the end members are urged against the interior surfaces of the spherical extremities of the body, thereby sealing the chamber.
In that sense, the seal between the end members and the extremities of the tubular body is provided by the engagement of the surfaces of the spherical peripheries of the end members against the interior surfaces of the spherical extremities of the body. No other sealing assemblies are typically required.
This particular configuration provides a much simple chamber without complex sealing arrangements such as, but not limited to, sealing rings, bolted flanges, etc., allowing the chamber to be easily dismantled or collapsed for transport and providing a better (e.g. continuous, uniform) seal at the interface between the end members and the extremities of the body.
One or both of the end members are typically provided with one or more inlets connectable to one or more sources of gases (e.g. a pressure generator, a hypoxic generator, etc.) such as to allow the chamber to receive a supply of gases to during hyperbaric or hypoxic treatment. One or both of the end members are also provided with one or more outlets to allow the gases to exit the chamber.
The chamber can advantageously be used with a supporting structure for receiving and supporting the chamber during use, and with a controlling system for controlling the conditions within the chamber during hyperbaric or hypoxic treatment. A non-limitative example of a possible supporting structure which incorporates the controlling system and the source(s) of gases (e.g. a pressure generator, a hypoxic generator, etc.) is shown in International patent application no. PCT/CA2007/001365 (published under no. WO 2008/014617).
Other and further aspects and advantages of the present invention will be obvious upon an understanding of the illustrative embodiments about to be described or will be indicated in the appended claims, and various advantages not referred to herein will occur to one skilled in the art upon employment of the invention in practice. The features of the present invention which are believed to be novel are set forth with particularity in the appended claims.
The above and other objects, features and advantages of the invention will become more readily apparent from the following description, reference being made to the accompanying drawings in which:
A novel portable chamber for hyperbaric and/or hypoxic treatment will be described hereinafter. Although the invention is described in terms of specific illustrative embodiments, it is to be understood that the embodiments described herein are by way of example only and that the scope of the invention is not intended to be limited thereby.
Referring now to the drawings, and more particularly to
The chamber system 10 comprises a chamber 100 suitable for hyperbaric and hypoxic treatments, as well as various sources (not shown) of gases (e.g. air, oxygen, etc.) to modify the conditions of air inside the chamber 100 with respect to the ambient conditions outside the chamber 100. These various sources, which typically include a pressure generator, a hypoxic generator and an oxygen source, are preferably, though not necessarily, all incorporated into the supporting structure 200 which supports the chamber 100 during treatment, and are in fluid communication with the interior of the chamber 100 via appropriate pipes, valves, inlets and outlets (not shown). These sources are also typically controlled by a control system 300, which can include a console. The control system 300 is operatively connected to the various sources such as to control the conditions within the chamber 100 during hyperbaric or hypoxic treatment. The control system 300 could also be operatively connected to diverse sensors located inside the chamber 100 and/or on the user undergoing a treatment to monitor the conditions inside the chamber 100 (e.g. ambient pressure, ambient oxygen level, etc.) and/or the conditions of the user (e.g. heartbeat, oxygen level in the blood, etc.). Such supporting structure 200 and control system 300 are known in the art (see for instance WO 2008/014617) and need not be described any further.
Still referring to
Referring to
As it will be explained below, the first end member 140 and the second end member 170 are configured to be respectively mounted inside the tubular body 110 at the first extremity 112 and at the second extremity 114 thereof. The end members 140 and 170 are further configured such that, when the chamber 100 is supplied with gases and thus pressurized, the end members 140 and 170 are respectively urged against the inner surfaces of the first and second extremities 112 and 114 of the tubular body 110, thereby sealing the chamber 100.
Referring now to each composing elements of the chamber 100, and starting with the tubular body 110, as best illustrated in
As best shown in
The tubular body 110 is made of a flexible and airtight reinforced elastomeric material. In the present embodiment, the elastomeric material is a latex-neoprene composition which is reinforced with aramid filaments 105 wound about the tubular body 110.
As best shown in
As the skilled addressee will understand, the winding of the filaments 105 extends along the whole length 103 of the tubular body 110.
Referring now to
The first extremity 112 therefore has a first radius of curvature 113 and a first opening 116 having a first diameter 117 while the second extremity 114 has a second radius of curvature 115, smaller than the first radius 113, and a second opening 118 having a second diameter 119.
In the present embodiment, the first and second diameters 117 and 119 are such that the reinforcing filaments 105 can be wound until the edges of the first and second openings.
Considering that the chamber 100 will be used for hyperbaric purposes, the material of the tubular body 110 is designed to be able to sustain positive relative pressures, typically up to 180 psig, without bursting. Under positive relative pressures, the chamber 100 will typically structurally maintain its shape.
Still, despite being made of reinforced elastomeric material, the tubular body 110 is flexible enough such that it can be collapsed as shown in
Referring now to
In the present embodiment, the end member 140 comprises an outer shell made of a fiberglass/epoxy composition, the shell having a polymeric foam core. The materials from which the end member 140 is made are preferably light such as to keep the overall weight of the chamber 100 low.
The first end member 140 comprises a first portion 142 which is located substantially inside the tubular body 110 during use, and a second portion 144 which extends outside of the tubular body 110 during use.
The first portion 142 defines a first exterior surface 146 which is substantially spherical in configuration. In that sense, the first exterior surface 146 generally has a radius of curvature 147 which is substantially equal to the radius of curvature 113 of the first extremity 112 of the tubular body 110. It is to be understood that the first exterior surface 146 is configured to engage the interior surface 123 of the first extremity 112 of the tubular body 110. It is thus important that the exterior shape of the first portion 142 of the first end member 140 generally matches the interior shape of the first extremity 112 of the tubular body 110 to prevent leaks when the chamber 100 is supplied with gases.
It is to be understood that in accordance with the principles of the present invention, there is no additional seal assembly between the first end member 140 and the first extremity 112 of the tubular body 110. In the end, the chamber 100 is ultimately sealed by the interaction between the first exterior surface 146 of the first end member 140 and the interior surface 123 of the first extremity 112 as the first end member 140 is urged axially under pressure.
The second portion 144, which extends from the first portion 142, comprises a radially extending lip or rim 148. The rim 148 is configured to cooperate with a locking ring assembly 160 to hold and lock the door assembly 150 in place.
Referring to
Referring more particularly to
As best shown in
Though not shown, the door assembly 150 could be advantageously provided with one or more handles to ease its manipulation.
As already introduced above, the door assembly 150 is configured to be secured to the second portion 144 of the first end member 140 with the aid of the locking ring assembly 160. In that sense, as best shown in
Referring now to
Referring to
Referring to
Referring now more particularly to
The remove the door assembly 150 from the first end member 140, the above procedure is substantially done in a reverse order.
In the present embodiment, each rod 163 is provided, at its free extremity, with a blocking element 168 such as, but not limited to, a safety screw with a transverse cotter pin, to prevent the knob 164 to be unscrewed beyond a predetermined point.
The skilled addressee will understand that the locking ring assembly 160 prevents accidental removal of the door assembly 150 even is one or both knobs 164 are accidentally unscrewed during a hyperbaric or a hypoxic treatment. Indeed, as long as the rods 163 are held and retained in their respective recessed portions 165 by the locking pins 167, both half rings 161 and 162 will remain attached together and will substantially circumscribe the door assembly 150.
The locking ring assembly 160 thus also adds a layer of safety to the operation of the chamber 100.
Referring now to
In the present embodiment, the second end member 170 comprises an outer shell made of a fiberglass/epoxy composition, the shell having a polymeric foam core. The materials from which the second end member 170 is made are preferably light such as to keep the overall weight of the chamber 100 low.
Typically, the second end member 170 is made of the same materials as the first end member 140.
The second end member 170 comprises a first portion 172 which is located substantially inside the tubular body 110 during use, and a second portion 174 which extends outside of the tubular body 110 during use.
The first portion 172 defines a second exterior surface 176 which is substantially spherical in configuration. In that sense, the second exterior surface 176 generally has a radius of curvature 177 which is substantially equal to the radius of curvature 115 of the second extremity 114 of the tubular body 110. It is to be understood that the second exterior surface 176 is configured to engage the interior surface 125 of the second extremity 114 of the tubular body 110. It is thus important that the exterior shape of the first portion 172 of the second end member 170 generally matches the interior shape of the second extremity 114 of the tubular body 110 to prevent leaks when the chamber 100 is supplied with gases.
Again, it is to be understood that in accordance with the principles of the present invention, as for the first end member 140, there is no additional seal assembly between the second end member 170 and the second extremity 114 of the tubular body 110. In the end, the chamber 100 is ultimately sealed by the interaction between the second exterior surface 176 of the second end member 170 and the interior surface 125 of the second extremity 114 as the second end member 170 is urged axially under pressure.
The second portion 174, which extends from the first portion 172, comprises a central opening 178 having an inner edge 179.
As shown in
As best shown in
In the normal assembled configuration of the chamber 100, the first portion 142 of the first end member 140 is mounted inside the tubular body 110 for engagement with the first extremity 112, and the first portion 172 of the second end member 170 is mounted inside the tubular body 110 for engagement with the second extremity 114.
In used, as the chamber 100 is supplied with gases during hyperbaric or hypoxic treatments, the gases will respectively axially push or urge the first end member 140, with the door assembly 150 mounted thereto, against the inner surface 123 of the first extremity 112, and the second end member 170 against the inner surface 125 of the second extremity 114. The engagement of the end members 140 and 170 with the respectively extremities 112 and 114 effectively seals the chamber 100 without additional seal assembly.
Hence, a chamber 100 in accordance with the principles of the present invention has a simpler configuration, is sturdy enough to sustain significant pressure (e.g. up to 180 psig), and is easily collapsible for storage and transport.
Though not shown, it is contemplated that the chamber 100 be provided with a mattress to support the user lying in the chamber 100 for treatment. The mattress could comprise a hinged structure to allow the user to take a seated position within the chamber 100. In addition, the mattress (e.g., synthetic foam material or similar material that will not affect the oxygen level in the chamber 100) would preferably be shaped to as to be received in the bottom of the chamber 100.
Though not shown, it is further contemplated that the chamber 100 be provided with handrails in order to facilitate movements inside the chamber 100 and/or to receive a stretcher (not shown). The handrails would preferably extend between the first and second end members 140 and 170 and would preferably be telescopic to facilitate transportation.
While illustrative and presently preferred embodiments of the invention have been described in detail hereinabove, it is to be understood that the inventive concepts may be otherwise variously embodied and employed and that the appended claims are intended to be construed to include such variations except insofar as limited by the prior art.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/CA10/01697 | 10/27/2010 | WO | 00 | 4/26/2013 |